-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Hold on Moderna, Raises Price Target to $90

Benzinga·10/21/2026 15:04:28
Listen to the news
TD Cowen analyst Tyler Van Buren maintains Moderna (NASDAQ:MRNA) with a Hold and raises the price target from $40 to $90.